Literature DB >> 21461859

Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells.

Luis Castro-Sanchez1, Adriana Soto-Guzman, Margarita Guaderrama-Diaz, Pedro Cortes-Reynosa, Eduardo Perez Salazar.   

Abstract

Discoidin domain receptors (DDRs) are receptor tyrosine kinases that get activated by collagens in its native triple-helical form. In mammalian cells, DDR family consists of two members, namely DDR1 and DDR2, which mediates migration and proliferation of several cell types. DDR1 is activated by native type IV collagen and overexpressed in human breast cancer. Type IV collagen is the main component of basement membrane (BM), and the ability to degrade and penetrate BM is related with an increased potential for invasion and metastasis. Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that collectively are capable of degrading all components of the extracellular matrix, including the BM. In breast cancer cells, denatured type IV collagen induces MMP-9 secretion and invasion. However, the role of DDR1 in the regulation of gelatinases (MMP-2 and -9) secretion and invasion in breast cancer cells remains to be studied. We demonstrate here that native type IV collagen induces MMP-2 and -9 secretions and invasion through a DDR1 and Src-dependent pathway, together with an increase of MMP-2 and -9-cell surface levels. MMP-2 and -9 secretions require PKC kinase activity, epidermal growth factor receptor (EGFR) activation, arachidonic acid (AA) production and AA metabolites in MDA-MB-231 breast cancer cells. In summary, our data demonstrate, for the first time, that DDR1 mediates MMP-2 and -9 secretions and invasion induced by native type IV collagen in MDA-MB-231 breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21461859     DOI: 10.1007/s10585-011-9385-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  110 in total

Review 1.  Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

2.  Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways.

Authors:  In-Kee Hong; Young-June Jin; Hee-Jung Byun; Doo-Il Jeoung; Young-Myeong Kim; Hansoo Lee
Journal:  J Biol Chem       Date:  2006-06-23       Impact factor: 5.157

Review 3.  Structure and biological activity of the extracellular matrix.

Authors:  M Aumailley; B Gayraud
Journal:  J Mol Med (Berl)       Date:  1998-03       Impact factor: 4.599

4.  Pharmacological manipulation of cyclo-oxygenase-2 in the inflamed hydronephrotic kidney.

Authors:  K Seibert; J L Masferrer; P Needleman; D Salvemini
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

5.  Type IV collagen induces STAT5 activation in MCF7 human breast cancer cells.

Authors:  Teresa Robledo; Lourdes Arriaga-Pizano; Mario Lopez-Pérez; Eduardo Pérez Salazar
Journal:  Matrix Biol       Date:  2005-09-01       Impact factor: 11.583

6.  Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in metastatic MDCK cells transformed by v-src.

Authors:  H Noritake; H Miyamori; C Goto; M Seiki; H Sato
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

Review 7.  Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis.

Authors:  C A C Hyde; S Missailidis
Journal:  Int Immunopharmacol       Date:  2009-02-23       Impact factor: 4.932

8.  Interaction of discoidin domain receptor 1 isoform b (DDR1b) with collagen activates p38 mitogen-activated protein kinase and promotes differentiation of macrophages.

Authors:  Wataru Matsuyama; Hidenobu Kamohara; Carole Galligan; Michel Faure; Teizo Yoshimura
Journal:  FASEB J       Date:  2003-05-08       Impact factor: 5.191

9.  Activation of discoidin domain receptor 1 facilitates the maturation of human monocyte-derived dendritic cells through the TNF receptor associated factor 6/TGF-beta-activated protein kinase 1 binding protein 1 beta/p38 alpha mitogen-activated protein kinase signaling cascade.

Authors:  Wataru Matsuyama; Michel Faure; Teizo Yoshimura
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

10.  Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo.

Authors:  J Xu; D Rodriguez; E Petitclerc; J J Kim; M Hangai; Y S Moon; G E Davis; P C Brooks; S M Yuen
Journal:  J Cell Biol       Date:  2001-09-03       Impact factor: 10.539

View more
  21 in total

1.  Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.

Authors:  Kathy A Toy; Rajeshwari R Valiathan; Fernando Núñez; Kelley M Kidwell; Maria E Gonzalez; Rafael Fridman; Celina G Kleer
Journal:  Breast Cancer Res Treat       Date:  2015-02-10       Impact factor: 4.872

Review 2.  Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Authors:  Rajeshwari R Valiathan; Marta Marco; Birgit Leitinger; Celina G Kleer; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

3.  Proteomic analysis of menstrual blood.

Authors:  Heyi Yang; Bo Zhou; Mechthild Prinz; Donald Siegel
Journal:  Mol Cell Proteomics       Date:  2012-07-20       Impact factor: 5.911

4.  Discoidin domain receptor 1: New star in cancer-targeted therapy and its complex role in breast carcinoma.

Authors:  Hui Jing; Jingyuan Song; Junnian Zheng
Journal:  Oncol Lett       Date:  2018-01-15       Impact factor: 2.967

5.  PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.

Authors:  Leah Rider; Peter Oladimeji; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2013-06-06

Review 6.  Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.

Authors:  Alan Hammer; Maria Diakonova
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

7.  Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.

Authors:  Jingyuan Song; Xiao Chen; Jin Bai; Qinghua Liu; Hui Li; Jianwan Xie; Hui Jing; Junnian Zheng
Journal:  Tumour Biol       Date:  2016-03-28

8.  High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma.

Authors:  Yanmiao Huo; Minwei Yang; Wei Liu; Jianyu Yang; Xueliang Fu; Dejun Liu; Jiao Li; Junfeng Zhang; Rong Hua; Yongwei Sun
Journal:  J Exp Clin Cancer Res       Date:  2015-08-22

9.  Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression.

Authors:  Nandini Rudra-Ganguly; Christine Lowe; Michael Mattie; Mi Sook Chang; Daulet Satpayev; Alla Verlinsky; Zili An; Liping Hu; Peng Yang; Pia Challita-Eid; David R Stover; Daniel S Pereira
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

10.  Integrin signaling in cancer cell survival and chemoresistance.

Authors:  Fawzi Aoudjit; Kristiina Vuori
Journal:  Chemother Res Pract       Date:  2012-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.